Back to WASATCH ADVISORS LP WASATCH ADVISORS LP

VKTXVKTX

Showing 9 of 15 quarters

Position history for WASATCH ADVISORS LPWASATCH ADVISORS LP's holdings in VIKING THERAPEUTICS INC

Yes. Wasatch Advisors holds 198,136 shares of VKTX (Viking Therapeutics), worth $6.5M, as of its Q3 2026 13F filing. It reduced the position by 114,631 shares (-36.7%) from Q2 2026. Wasatch Advisors has held VKTX since Q1 2023, across 15 quarterly 13F filings.

Current Value

$6.5M

Current Shares

198,136

Total Value Change

-$8M

Total Shares Change

-29,584

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Decreased
198,136
-36.6%
$6.5M0.0%$32.60
0
2026-Q2
Decreased
312,767
-0.1%
$12.2M0.1%$39.01
0
2026-Q1
Increased
313,158
+89.3%
$10.2M0.1%$32.54
44
2025-Q4
Increased
165,406
+28.8%
$5.8M0.0%$35.18
34
2025-Q3
Decreased
128,467
-51.0%
$3.4M0.0%$26.28
0
2025-Q2
Increased
262,045
+1.8%
$6.9M0.0%$26.50
28
2025-Q1
Increased
257,448
+42.3%
$6.2M0.0%$24.15
36
2024-Q4
Decreased
180,918
-20.6%
$7.3M0.0%$40.24
0
2024-Q3
Decreased
227,720
-10.1%
$14.4M0.1%$63.31
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used